You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 20, 2025

Drug Price Trends for NDC 70000-0156


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 70000-0156

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Drug NDC: 70000-0156

Understanding the NDC Directory

To analyze the market and project prices for a specific drug, it is crucial to start with the National Drug Code (NDC) directory. The NDC directory, maintained by the FDA, lists unique NDCs for all marketed drug products in the U.S. The NDC 70000-0156 identifies a specific drug product, including the labeler, product, and trade package size[4].

Identifying the Drug

Using the NDC directory, one can search for the drug associated with NDC 70000-0156. For example, if we search by the NDC number, the directory will provide details such as the proprietary name, non-proprietary name, dosage form, route of administration, beginning and end marketing dates, application number, labeler name, strength, package code, and package description[1].

Market Trends and Price Inflation

Overall Drug Price Inflation

The pharmaceutical market is experiencing ongoing price inflation. According to Vizient's Pharmacy Market Outlook, the overall drug price inflation rate for 2025 is projected to be 3.81%. This inflation is driven by factors such as expanding indications for previously approved medications and the introduction of high-cost cell and gene therapies[3].

Specific Drug Price Changes

The list prices of prescription drugs can change significantly over time. From January 2022 to January 2023, the average price increase for single-source drugs was 7.4%, while multi-source drugs saw an average increase of 26.0%[5].

Price Negotiations and Regulatory Impact

Medicare Drug Price Negotiation Program

Beginning in January 2026, the Medicare Drug Price Negotiation Program will come into effect, with the first 10 negotiated prices set to reduce list prices significantly. For example, negotiations have resulted in discounts ranging from 38% to 79% compared to list prices[2].

Case Study: Similar Drugs

To project the price of a specific drug like NDC 70000-0156, it is helpful to look at similar drugs. For instance, semaglutide (Ozempic® and Wegovy®), which has seen a 77% increase in spend due to expanded indications, can serve as a benchmark. These medications, used for diabetes and obesity, have recently been approved for reducing the risk of major adverse cardiovascular events, leading to increased demand and spend[3].

Factors Influencing Price Projections

Expanding Indications

Drugs with expanding indications, such as GLP-1 agents like semaglutide, are likely to see increased demand and potentially higher prices. This trend can be a significant factor in projecting future prices for drugs with similar profiles[3].

Regulatory Changes

Regulatory changes, such as those introduced by the Medicare Drug Price Negotiation Program, can significantly impact drug prices. These negotiations can lead to substantial discounts, which may influence the pricing strategy for other drugs in the market[2].

Market Competition

The level of competition in the market also plays a crucial role. Multi-source drugs tend to have higher percentage price increases but lower absolute dollar increases compared to single-source drugs. Understanding the competitive landscape is essential for accurate price projections[5].

Data Analysis and Tools

NDC Directory Search

Using the NDC directory, one can gather detailed information about the drug, including its marketing history, dosage forms, and package sizes. This data is crucial for analyzing market trends and projecting future prices[1].

Wholesale Acquisition Cost (WAC)

The Wholesale Acquisition Cost (WAC) is a key metric in determining drug prices. Analyzing WAC changes over time can provide insights into the potential future price movements of a drug[5].

Price Projection for NDC 70000-0156

Given the current market trends and factors influencing drug prices:

  • Inflation Rate: With an overall drug price inflation rate of 3.81% projected for 2025, it is likely that the price of NDC 70000-0156 will increase by a similar margin.
  • Regulatory Impact: If the drug falls under the Medicare Drug Price Negotiation Program or similar regulatory changes, it may experience significant price reductions.
  • Expanding Indications: If the drug has or is likely to have expanded indications, this could drive up demand and prices.
  • Market Competition: The level of competition in the market will also influence the price projection.

Example Calculation

Assuming the current price of the drug associated with NDC 70000-0156 is $100 per unit and considering the projected inflation rate:

  • Projected Price Increase: 3.81% of $100 = $3.81
  • New Price: $100 + $3.81 = $103.81

However, if the drug is subject to significant regulatory discounts or has expanding indications, the actual price could vary substantially.

Key Takeaways

  • NDC Directory: Essential for identifying and gathering detailed information about the drug.
  • Market Trends: Overall drug price inflation rates and specific trends for similar drugs are crucial for projections.
  • Regulatory Changes: Programs like the Medicare Drug Price Negotiation Program can significantly impact prices.
  • Expanding Indications: Can drive up demand and prices.
  • Market Competition: Influences the magnitude of price changes.

FAQs

Q: What is the NDC directory, and how is it used? A: The NDC directory is a resource maintained by the FDA that lists unique National Drug Codes for all marketed drug products in the U.S. It is used to identify and gather detailed information about drugs, including their marketing history, dosage forms, and package sizes[1].

Q: How does the Medicare Drug Price Negotiation Program affect drug prices? A: The program negotiates prices for certain drugs, resulting in discounts ranging from 38% to 79% compared to list prices. This can significantly reduce the cost of these drugs for Medicare Part D beneficiaries[2].

Q: What factors influence the price projections for a specific drug? A: Factors include the overall drug price inflation rate, regulatory changes, expanding indications, and the level of market competition[3][5].

Q: How can the Wholesale Acquisition Cost (WAC) be used in price projections? A: Analyzing changes in WAC over time provides insights into potential future price movements of a drug. It is a key metric in determining drug prices[5].

Q: What is the significance of expanding indications for drug prices? A: Expanding indications can drive up demand and prices for drugs, as seen with GLP-1 agents like semaglutide. This trend can be a significant factor in projecting future prices[3].

Sources

  1. FDA, "NDC Directory (March 2015) - FDA".
  2. ASPE, "Medicare Drug Price Negotiation Program - ASPE - HHS.gov".
  3. Vizient, "Vizient projects drug price inflation at 3.81%".
  4. FDA, "National Drug Code Database Background Information - FDA".
  5. ASPE, "Changes in the List Prices of Prescription Drugs, 2017-2023 - ASPE".

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.